ELMD Stock Analysis: Buy, Sell, or Hold?
ELMD - Electromed, Inc.
$38.22
-0.36 (-0.93%)
▼
5d:
+7.12%
30d:
+50.0%
90d:
+56.58%
HOLD
MODERATE Confidence
Analysis Updated: May 22, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Get Alerted When ELMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: ELMD is 10.9% above its trading range ($34.47). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: ELMD is 10.9% above its trading range ($34.47). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$57.61
Based on 12.8% avg growth
INTRINSIC VALUE TODAY
$35.77
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ELMD is currently trading at $38.22, which is considered extended relative to its 30-day fair value range of $24.01 to $34.47. From a valuation perspective, the stock is trading at a premium (Forward PE: 26.1) compared to its historical average (21.7). At these levels, the market is pricing in 6.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ELMD is showing sideways momentum. The price is approaching resistance at $39.25. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ELMD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ELMD is showing sideways momentum. The price is approaching resistance at $39.25. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ELMD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$24.01 -
$34.47
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
56.9%
Protect Your Profits
ELMD is technically overbought (RSI 79). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+10.9% above its trading range)
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($38.00)
- NEUTRAL: Trading at premium valuation - market expects 6.3% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$24.01 -
$34.47
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$2.24
(5.9%)
Support & Resistance Levels
Support Level
$25.70
Resistance Level
$39.25
Current Trend
Sideways
Technical data as of
May 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
26.09
Wall Street Target
$38.00
(-0.6%)
Revenue Growth (YoY)
18.4%
Earnings Growth (YoY)
66.7%
Profit Margin
14.1%
Valuation Premium vs History
+6.3% premium
PE vs Historical
26.1 vs 21.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.3%
(market-implied from PE analysis)
1-Year Target
$40.63
(+6%)
2-Year Target
$43.19
(+13%)
3-Year Target
$45.91
(+20%)
3-Yr Target (if PE normalizes)
(PE: 26→22)
PE COMPRESSION
$38.19
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 26.1, Growth: 21.6%)
$68.68
(+80%)
Base:
(SPY PE: 22.0, Growth: 21.6%)
$57.89
(+52%)
Bear:
(PE: 18.7, Growth: 21.6%)
$49.21
(+29%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (32x PE), but valuation improves significantly next year (26x PE) as earnings recover.
Trailing PE: 32.15 | Current EPS (TTM): $1.20
Bull Case
$51.81
(+36%)
Analyst growth 22.1%, PE expands to 35.4
Base Case
$47.10
(+23%)
Market implied 22.1%, PE stable at 32.2
Bear Case
$26.23
(-31%)
Severe decline -20.0%, PE contracts to 27.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: May 25, 2026 9:59 PM ET
Data refreshes hourly during market hours. Next update: 10:59 PM
Data refreshes hourly during market hours. Next update: 10:59 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$83 | 62 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$82 | 64 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 62 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$107 | 62 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 67 BUY |
Advanced ELMD Option Strategies
Professional options setups generated by AI based on today's ELMD price and gamma walls.
